DD128866A5 - Verfahren zur herstellung von durch einen chromonylrest substituierten propionsaeuren - Google Patents
Verfahren zur herstellung von durch einen chromonylrest substituierten propionsaeurenInfo
- Publication number
- DD128866A5 DD128866A5 DD7500189584A DD18958475A DD128866A5 DD 128866 A5 DD128866 A5 DD 128866A5 DD 7500189584 A DD7500189584 A DD 7500189584A DD 18958475 A DD18958475 A DD 18958475A DD 128866 A5 DD128866 A5 DD 128866A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- propione
- chromonyl
- acids
- substituted
- resistant
- Prior art date
Links
- FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical class CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/28—Halogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/455—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation with carboxylic acids or their derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
- C07C49/83—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/46—Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
- C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pain & Pain Management (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7438080A FR2291745A1 (fr) | 1974-11-20 | 1974-11-20 | Nouveaux acides inferieurs substitues par un radical chromonyl, leurs derives et leurs applications |
FR7531024A FR2326919A2 (fr) | 1975-10-10 | 1975-10-10 | Nouveaux acides inferieurs substitues par un radical chromonyle, leurs derives et leurs applications |
Publications (1)
Publication Number | Publication Date |
---|---|
DD128866A5 true DD128866A5 (de) | 1977-12-14 |
Family
ID=26218606
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD7500189584A DD128866A5 (de) | 1974-11-20 | 1975-11-20 | Verfahren zur herstellung von durch einen chromonylrest substituierten propionsaeuren |
Country Status (15)
Country | Link |
---|---|
US (1) | US4097582A (de) |
JP (1) | JPS6039676B2 (de) |
AT (1) | AT345829B (de) |
CA (1) | CA1067074A (de) |
CH (1) | CH612193A5 (de) |
DD (1) | DD128866A5 (de) |
DE (1) | DE2549745A1 (de) |
DK (1) | DK519975A (de) |
ES (1) | ES442616A1 (de) |
GB (1) | GB1512537A (de) |
IE (1) | IE43539B1 (de) |
IL (1) | IL48465A (de) |
MX (1) | MX3009E (de) |
NL (1) | NL7513597A (de) |
NO (1) | NO146636C (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3125870C2 (de) * | 1980-07-09 | 1994-09-15 | William John Louis | 3-Aminopropoxyphenyl Derivate, ihre Herstellung und sie enthaltende Arzneimittel |
FR2516922A1 (fr) * | 1981-11-25 | 1983-05-27 | Lipha | Acides (oxo-4-4h-(1)-benzopyran-8-yl) alcanoiques, sels et derives, preparation et medicament les contenant |
JPS61118380A (ja) * | 1984-11-14 | 1986-06-05 | Shionogi & Co Ltd | 新規な1,4−ベンゾジオキサンおよび1,4−ベンゾジオキシン誘導体ならびにその製造法 |
US5116954A (en) * | 1988-04-06 | 1992-05-26 | Lipha, Lyonnaise Industrielle Pharmaceutique | Pharmaceutically useful flavonoic compounds containing at least one substituent on the benzopyranone ring moiety |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1499323A (en) * | 1974-03-22 | 1978-02-01 | Fisons Ltd | 6-substituted chromones and chromanones |
-
1975
- 1975-11-06 DE DE19752549745 patent/DE2549745A1/de not_active Withdrawn
- 1975-11-11 IL IL48465A patent/IL48465A/xx unknown
- 1975-11-11 CH CH1460375A patent/CH612193A5/xx not_active IP Right Cessation
- 1975-11-12 US US05/631,401 patent/US4097582A/en not_active Expired - Lifetime
- 1975-11-14 CA CA239,665A patent/CA1067074A/en not_active Expired
- 1975-11-14 ES ES442616A patent/ES442616A1/es not_active Expired
- 1975-11-18 IE IE2518/75A patent/IE43539B1/en unknown
- 1975-11-19 MX MX002840U patent/MX3009E/es unknown
- 1975-11-19 GB GB47707/75A patent/GB1512537A/en not_active Expired
- 1975-11-19 NO NO753886A patent/NO146636C/no unknown
- 1975-11-19 DK DK519975A patent/DK519975A/da not_active Application Discontinuation
- 1975-11-20 DD DD7500189584A patent/DD128866A5/de unknown
- 1975-11-20 JP JP50138775A patent/JPS6039676B2/ja not_active Expired
- 1975-11-20 NL NL7513597A patent/NL7513597A/xx not_active Application Discontinuation
- 1975-11-20 AT AT884275A patent/AT345829B/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO146636C (no) | 1982-11-10 |
ATA884275A (de) | 1978-02-15 |
IE43539B1 (en) | 1981-03-25 |
JPS6039676B2 (ja) | 1985-09-06 |
US4097582A (en) | 1978-06-27 |
GB1512537A (en) | 1978-06-01 |
AT345829B (de) | 1978-10-10 |
DK519975A (da) | 1976-05-21 |
NO753886L (de) | 1976-05-21 |
IE43539L (en) | 1976-05-20 |
NL7513597A (nl) | 1976-05-24 |
IL48465A (en) | 1981-06-29 |
CH612193A5 (de) | 1979-07-13 |
JPS51125288A (en) | 1976-11-01 |
CA1067074A (en) | 1979-11-27 |
ES442616A1 (es) | 1977-12-01 |
MX3009E (es) | 1980-01-28 |
IL48465A0 (en) | 1976-01-30 |
NO146636B (no) | 1982-08-02 |
AU8670775A (en) | 1977-05-26 |
DE2549745A1 (de) | 1976-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AT341504B (de) | Verfahren zur herstellung von alfa-arylpropionsauren | |
AT338420B (de) | Verfahren zur herstellung von adriamycinen | |
AT363889B (de) | Verfahren zur herstellung von enzympraeparaten | |
AT347130B (de) | Verfahren zur herstellung von terpolymerisaten | |
AT338750B (de) | Verfahren zur herstellung von alkenylbernsteinsaureanhydriden | |
AT341792B (de) | Verfahren zur herstellung von schichtstrukturen | |
ATA734575A (de) | Verfahren zur herstellung von 5-fluor-2-methyl-1- (p-methylsulfinylbenzyliden)-indenyl-3-essigsaure | |
DD128866A5 (de) | Verfahren zur herstellung von durch einen chromonylrest substituierten propionsaeuren | |
ATA329875A (de) | Verfahren zur herstellung von salzen von poly-alfa-hydroxyacrylsauren | |
AT340133B (de) | Verfahren zur herstellung von athylenpolymerisaten | |
ATA940875A (de) | Verfahren zur herstellung von 7-acylamido-3-methyl-3-cephem-4-carbonsaureestern | |
AT335993B (de) | Verfahren zur herstellung von atherpolycarbonsauren | |
AT338422B (de) | Verfahren zur herstellung von cephalosporinen | |
AT340047B (de) | Verfahren zur herstellung von cephalosporinen | |
ATA309976A (de) | Verfahren zur herstellung von sulfamylbenzoesauren | |
AT359215B (de) | Verfahren zur herstellung von pgfbeta-prosta- glandinen | |
DD114089A5 (de) | Verfahren zur herstellung von halogenhaltigen tertiaeren phosphinoziden | |
AT330797B (de) | Verfahren zur herstellung von tertiaren phosphinoxiden | |
AT339925B (de) | Verfahren zur herstellung von beta-chlorathyltrichlorsilan | |
AT344171B (de) | Verfahren zur herstellung von indolyl-pyridyl-ketonen | |
AT338756B (de) | Verfahren zur herstellung von alfa-amino-1-adamantylessigsaure | |
AT347917B (de) | Verfahren zur herstellung von 2-dihalogen- vinylcyclopropancarbonsaeureestern | |
AT333699B (de) | Verfahren zur herstellung von magnesiumoxid | |
ATA233075A (de) | Verfahren zur herstellung von 16alpha- und 16beta-methal-9alpha-chlor- oder -flour-21- -desoxyprednisolonestern und -aethern | |
AT338819B (de) | Verfahren zur herstellung von carbanilsaureestern |